Brain natriuretic peptide predicts mortality in the elderly

Heart

Volumn 77, Issue 3, 1997, Pages 264-267

  Wallén, Thomas ^a,d   Landahl, Sten ^a   Hedner, Thomas ^b   Nakao, Kazuwa ^c   Saito, Yoshihiko ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KYOTO UNIVERSITY   (Japan)

^d Vasa Hospital   (Sweden)

Author keywords

Brain natriuretic peptide; Elderly patients; Epidemiology; Mortality

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

EID: 0030986077     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.3.264     Document Type: Article

References (19)

1. Sudoh T, Kangawa K, Minamino M, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332: 78-81.
2. McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990;70: 1103-7.
3. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S-I, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323: 757-8.
4. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Monta E, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991;180:431-6.
5. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K-I, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92: 29-34.
6. Gottlieb SS, Kukin ML, Ahem D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-9.
7. Hall C, Rouleau JL, Moyè L, de Champlain J, Bichet D, Klein M, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89:1934-42.
8. Rinder L, Roupe S, Steen B, Svanborg A. Seventy-year-old people in Gothenburg: a population study in an industrialized Swedish city. I. General presentation of the study. Acta Med Scand 1975;198:397-407.
9. Landahl S, Svanborg A, Åstrand K. Heart volume and the prevalence of certain common cardiovascular disorders at 70 and 75 years of age. Eur Heart J 1984;5:326-31.
10. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull WHO 1962;27: 645-58.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearence from serum creatinine. Nephron 1976;16: 31-41.
12. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90:195-203.
13. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma levels of brain natriuretic peptide and myocardial infarct size. Cardiology 1994;85: 334-40.
14. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
15. Omland T, Aakvaag A, Bonarjee V, Caidahl K, Lie RT, Nilsen D, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996;93:1963-9.
16. Lernfelt B, Wikstrand J, Svanborg A, Landahl S. Aging and left ventricular function in elderly healthy people. Am J Cardiol 1991;68:547-9.
17. Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989;63:1526-8.
18. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
19. Francis GS, Benedict C, Johnstone DE, Benedict C, Johnstone EJ, Kirlin PC, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.